Janiczek Wealth Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$10 Sell
1
-22
-96% -$268 ﹤0.01% 1087
2024
Q1
$348 Hold
23
﹤0.01% 1025
2023
Q4
$496 Hold
23
﹤0.01% 1003
2023
Q3
$428 Hold
23
﹤0.01% 991
2023
Q2
$583 Hold
23
﹤0.01% 894
2023
Q1
$589 Buy
23
+22
+2,200% +$589 ﹤0.01% 896
2022
Q4
$26 Hold
1
﹤0.01% 1025
2022
Q3
$0 Hold
1
﹤0.01% 1052
2022
Q2
$0 Sell
1
-15
-94% -$637 ﹤0.01% 1065
2022
Q1
$1K Sell
16
-48
-75% -$3.46K ﹤0.01% 903
2021
Q4
$6K Buy
64
+29
+83% +$3.47K ﹤0.01% 684
2021
Q3
$4K Buy
35
+19
+119% +$2.77K ﹤0.01% 737
2021
Q2
$3K Sell
16
-53
-77% -$8.59K ﹤0.01% 731
2021
Q1
$13K Buy
69
+54
+360% +$12.5K 0.01% 477
2020
Q4
$3K Buy
15
+10
+200% +$2.03K ﹤0.01% 657
2020
Q3
$1K Buy
+5
New +$1.06K ﹤0.01% 608

Other funds holding TDOC

Janiczek Wealth Management's TDOC Position: Q2 2024 in Review

Janiczek Wealth Management reduced its Teladoc Health (TDOC) stake by 96% in Q2 2024, selling an estimated $268 and leaving 1 share worth $10. The position accounts for ﹤0.01% of the portfolio, ranked #1087.

Janiczek Wealth Management first reported a position in TDOC in Q3 2020 and has held it in 16 quarters since. The position peaked at $13K in Q1 2021. 407 funds tracked by Wall St. Rank hold TDOC as of Q2 2024.

  • Janiczek Wealth Management held 1 share of Teladoc Health worth $10 as of Q2 2024.
  • Janiczek Wealth Management sold 22 Teladoc Health shares in Q2 2024, an estimated $268.
  • Teladoc Health made up ﹤0.01% of Janiczek Wealth Management's portfolio in Q2 2024, its #1087 holding.
  • Janiczek Wealth Management first reported a position in Teladoc Health in Q3 2020 and has held it in 16 quarters since.
  • Janiczek Wealth Management's Teladoc Health position peaked at $13K in Q1 2021.
  • 407 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2024.

Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.